BNP Paribas Arbitrage SA Sells 3,095 Shares of Magellan Health Inc (MGLN)  Donna Armstrong | Aug 17th, 2018
BNP Paribas Arbitrage SA decreased its holdings in Magellan Health Inc (NASDAQ:MGLN) by 39.4% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 4,760 shares of the company's stock after selling 3,095 shares during the quarter. BNP Paribas Arbitrage SA's holdings in Magellan Health were worth $457,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also bought and sold shares of MGLN. Natixis purchased a new position in shares of Magellan Health in the first quarter valued at approximately $213,000. Trexquant Investment LP purchased a new position in shares of Magellan Health in the first quarter valued at approximately $260,000. WINTON GROUP Ltd purchased a new position in shares of Magellan Health in the first quarter valued at approximately $275,000. Suntrust Banks Inc. purchased a new position in shares of Magellan Health in the first quarter valued at approximately $283,000. Finally, Assenagon Asset Management S.A. purchased a new position in shares of Magellan Health in the second quarter valued at approximately $388,000. 94.26% of the stock is owned by institutional investors and hedge funds. Get Magellan Health alerts:
In related news, CEO Barry M. Smith sold 13,375 shares of Magellan Health stock in a transaction that occurred on Friday, June 1st. The shares were sold at an average price of $92.21, for a total value of $1,233,308.75. Following the completion of the transaction, the chief executive officer now owns 43,914 shares in the company, valued at $4,049,309.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink . 4.60% of the stock is owned by insiders.
Shares of Magellan Health stock opened at $74.85 on Friday. Magellan Health Inc has a 52-week low of $71.03 and a 52-week high of $112.25. The company has a quick ratio of 1.58, a current ratio of 1.63 and a debt-to-equity ratio of 0.56. The company has a market capitalization of $1.86 billion, a P/E ratio of 13.61, a PEG ratio of 1.66 and a beta of 0.40.
Magellan Health (NASDAQ:MGLN) last issued its quarterly earnings results on Friday, July 27th. The company reported $0.91 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.06 by ($0.15). Magellan Health had a return on equity of 11.29% and a net margin of 1.66%. The firm had revenue of $1.81 billion during the quarter, compared to analysts' expectations of $1.88 billion. During the same quarter in the prior year, the firm earned $0.59 EPS. The firm's revenue was up 27.6% compared to the same quarter last year. equities research analysts anticipate that Magellan Health Inc will post 4.55 EPS for the current fiscal year.
Several research firms have recently commented on MGLN. Zacks Investment Research raised shares of Magellan Health from a "strong sell" rating to a "buy" rating and set a $108.00 price objective for the company in a research note on Wednesday, July 4th. ValuEngine downgraded shares of Magellan Health from a "strong-buy" rating to a "buy" rating in a research note on Thursday, April 26th. BidaskClub upgraded shares of Magellan Health from a "buy" rating to a "strong-buy" rating in a research note on Thursday, May 31st. Finally, Raymond James upgraded shares of Magellan Health from a "market perform" rating to an "outperform" rating in a research note on Tuesday, May 1st. Two equities research analysts have rated the stock with a sell rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of "Buy" and a consensus target price of $98.00.
Magellan Health Profile
Magellan Health, Inc provides healthcare management services in the United States. It operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine for health plans, care organizations, and employers.
Read More: Stock Symbols and CUSIP Explained
Want to see what other hedge funds are holding MGLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Magellan Health Inc (NASDAQ:MGLN). Magellan Health Magellan Healt